Larimar Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative treatments for patients with complex rare diseases. Utilizing its unique cell penetrating peptide technology platform, Larimar focuses on delivering critical therapies, including its lead candidate Nomlabofusp, aimed at enhancing mitochondrial function in patients with Friedreich's ataxia.
No jobs found. Subscribe below to get notified when we find something for you.
Searching